Potential negative impact of reputed regulators’ decisions on the approval status of new cancer drugs in Latin American countries: A descriptive analysis

• Carlos E. Durán ,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Writing – original draft, Writing – review & editing

  * E-mail: carlos.duran@ugent.be

  Affiliation Clinical Pharmacology Research Group, Department of Basic and Applied Medical Sciences, Ghent University, Ghent, Belgium

  https://orcid.org/0000-0003-1853-3641

  ⨯
• Martín Cañás,

  Roles Data curation, Formal analysis, Investigation, Writing – review & editing

  Affiliations Federación Médica de la Provincia de Buenos Aires, La Plata, Argentina, Instituto de Ciencias de la Salud, Universidad Nacional Arturo Jauretche, Florencio Varela, Argentina

  https://orcid.org/0000-0003-0500-5866

  ⨯
• Martín Urtasun,

  Roles Formal analysis, Investigation, Writing – review & editing

  Affiliations Federación Médica de la Provincia de Buenos Aires, La Plata, Argentina, Instituto de Ciencias de la Salud, Universidad Nacional Arturo Jauretche, Florencio Varela, Argentina

  ⨯
• Monique Elseviers,

  Roles Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – review & editing

  Affiliation Clinical Pharmacology Research Group, Department of Basic and Applied Medical Sciences, Ghent University, Ghent, Belgium

  ⨯
• Robert Vander Stichele,

  Roles Methodology, Writing – review & editing

  Affiliation Clinical Pharmacology Research Group, Department of Basic and Applied Medical Sciences, Ghent University, Ghent, Belgium

  ⨯
• Thierry Christiaens

  Roles Conceptualization, Methodology, Supervision, Writing – review & editing

  Affiliation Clinical Pharmacology Research Group, Department of Basic and Applied Medical Sciences, Ghent University, Ghent, Belgium

  ⨯